PVA Embolization Particles - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245612

Publication Date:

September 20, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global market for PVA Embolization Particles was estimated to be worth US$ 831 million in 2023 and is forecast to a readjusted size of US$ 1186.9 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030
North American market for PVA Embolization Particles was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PVA Embolization Particles was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for PVA Embolization Particles was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of PVA Embolization Particles include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PVA Embolization Particles, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of PVA Embolization Particles by region & country, by Type, and by Application.
The PVA Embolization Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PVA Embolization Particles.
麻豆原创 Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Segment by Type:
Conventional/Irregular PVA
Compressible and Spherical PVA
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of PVA Embolization Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of PVA Embolization Particles in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 PVA Embolization Particles Product Introduction
1.2 Global PVA Embolization Particles 麻豆原创 Size Forecast
1.2.1 Global PVA Embolization Particles Sales Value (2019-2030)
1.2.2 Global PVA Embolization Particles Sales Volume (2019-2030)
1.2.3 Global PVA Embolization Particles Sales Price (2019-2030)
1.3 PVA Embolization Particles 麻豆原创 Trends & Drivers
1.3.1 PVA Embolization Particles Industry Trends
1.3.2 PVA Embolization Particles 麻豆原创 Drivers & Opportunity
1.3.3 PVA Embolization Particles 麻豆原创 Challenges
1.3.4 PVA Embolization Particles 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global PVA Embolization Particles Players Revenue Ranking (2023)
2.2 Global PVA Embolization Particles Revenue by Company (2019-2024)
2.3 Global PVA Embolization Particles Players Sales Volume Ranking (2023)
2.4 Global PVA Embolization Particles Sales Volume by Company Players (2019-2024)
2.5 Global PVA Embolization Particles Average Price by Company (2019-2024)
2.6 Key Manufacturers PVA Embolization Particles Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers PVA Embolization Particles Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of PVA Embolization Particles
2.9 PVA Embolization Particles 麻豆原创 Competitive Analysis
2.9.1 PVA Embolization Particles 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by PVA Embolization Particles Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PVA Embolization Particles as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Conventional/Irregular PVA
3.1.2 Compressible and Spherical PVA
3.2 Global PVA Embolization Particles Sales Value by Type
3.2.1 Global PVA Embolization Particles Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global PVA Embolization Particles Sales Value, by Type (2019-2030)
3.2.3 Global PVA Embolization Particles Sales Value, by Type (%) (2019-2030)
3.3 Global PVA Embolization Particles Sales Volume by Type
3.3.1 Global PVA Embolization Particles Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global PVA Embolization Particles Sales Volume, by Type (2019-2030)
3.3.3 Global PVA Embolization Particles Sales Volume, by Type (%) (2019-2030)
3.4 Global PVA Embolization Particles Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Uterine Fibroid Embolization
4.1.2 Prostatic Artery Embolization
4.1.3 Liver Tumor Embolization
4.1.4 Trauma Embolization
4.1.5 Other
4.2 Global PVA Embolization Particles Sales Value by Application
4.2.1 Global PVA Embolization Particles Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global PVA Embolization Particles Sales Value, by Application (2019-2030)
4.2.3 Global PVA Embolization Particles Sales Value, by Application (%) (2019-2030)
4.3 Global PVA Embolization Particles Sales Volume by Application
4.3.1 Global PVA Embolization Particles Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global PVA Embolization Particles Sales Volume, by Application (2019-2030)
4.3.3 Global PVA Embolization Particles Sales Volume, by Application (%) (2019-2030)
4.4 Global PVA Embolization Particles Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global PVA Embolization Particles Sales Value by Region
5.1.1 Global PVA Embolization Particles Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global PVA Embolization Particles Sales Value by Region (2019-2024)
5.1.3 Global PVA Embolization Particles Sales Value by Region (2025-2030)
5.1.4 Global PVA Embolization Particles Sales Value by Region (%), (2019-2030)
5.2 Global PVA Embolization Particles Sales Volume by Region
5.2.1 Global PVA Embolization Particles Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global PVA Embolization Particles Sales Volume by Region (2019-2024)
5.2.3 Global PVA Embolization Particles Sales Volume by Region (2025-2030)
5.2.4 Global PVA Embolization Particles Sales Volume by Region (%), (2019-2030)
5.3 Global PVA Embolization Particles Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America PVA Embolization Particles Sales Value, 2019-2030
5.4.2 North America PVA Embolization Particles Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe PVA Embolization Particles Sales Value, 2019-2030
5.5.2 Europe PVA Embolization Particles Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific PVA Embolization Particles Sales Value, 2019-2030
5.6.2 Asia Pacific PVA Embolization Particles Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America PVA Embolization Particles Sales Value, 2019-2030
5.7.2 South America PVA Embolization Particles Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa PVA Embolization Particles Sales Value, 2019-2030
5.8.2 Middle East & Africa PVA Embolization Particles Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions PVA Embolization Particles Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions PVA Embolization Particles Sales Value
6.2.1 Key Countries/Regions PVA Embolization Particles Sales Value, 2019-2030
6.2.2 Key Countries/Regions PVA Embolization Particles Sales Volume, 2019-2030
6.3 United States
6.3.1 United States PVA Embolization Particles Sales Value, 2019-2030
6.3.2 United States PVA Embolization Particles Sales Value by Type (%), 2023 VS 2030
6.3.3 United States PVA Embolization Particles Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe PVA Embolization Particles Sales Value, 2019-2030
6.4.2 Europe PVA Embolization Particles Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe PVA Embolization Particles Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China PVA Embolization Particles Sales Value, 2019-2030
6.5.2 China PVA Embolization Particles Sales Value by Type (%), 2023 VS 2030
6.5.3 China PVA Embolization Particles Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan PVA Embolization Particles Sales Value, 2019-2030
6.6.2 Japan PVA Embolization Particles Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan PVA Embolization Particles Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea PVA Embolization Particles Sales Value, 2019-2030
6.7.2 South Korea PVA Embolization Particles Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea PVA Embolization Particles Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia PVA Embolization Particles Sales Value, 2019-2030
6.8.2 Southeast Asia PVA Embolization Particles Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia PVA Embolization Particles Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India PVA Embolization Particles Sales Value, 2019-2030
6.9.2 India PVA Embolization Particles Sales Value by Type (%), 2023 VS 2030
6.9.3 India PVA Embolization Particles Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sirtex Medical
7.1.1 Sirtex Medical Company Information
7.1.2 Sirtex Medical Introduction and Business Overview
7.1.3 Sirtex Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sirtex Medical PVA Embolization Particles Product Offerings
7.1.5 Sirtex Medical Recent Development
7.2 Merit Medical
7.2.1 Merit Medical Company Information
7.2.2 Merit Medical Introduction and Business Overview
7.2.3 Merit Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merit Medical PVA Embolization Particles Product Offerings
7.2.5 Merit Medical Recent Development
7.3 Cook Medical
7.3.1 Cook Medical Company Information
7.3.2 Cook Medical Introduction and Business Overview
7.3.3 Cook Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cook Medical PVA Embolization Particles Product Offerings
7.3.5 Cook Medical Recent Development
7.4 BTG Medical
7.4.1 BTG Medical Company Information
7.4.2 BTG Medical Introduction and Business Overview
7.4.3 BTG Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.4.4 BTG Medical PVA Embolization Particles Product Offerings
7.4.5 BTG Medical Recent Development
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Company Information
7.5.2 Boston Scientific Corporation Introduction and Business Overview
7.5.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Boston Scientific Corporation PVA Embolization Particles Product Offerings
7.5.5 Boston Scientific Corporation Recent Development
7.6 Terumo Corporation
7.6.1 Terumo Corporation Company Information
7.6.2 Terumo Corporation Introduction and Business Overview
7.6.3 Terumo Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Terumo Corporation PVA Embolization Particles Product Offerings
7.6.5 Terumo Corporation Recent Development
7.7 HENGRUI Medical
7.7.1 HENGRUI Medical Company Information
7.7.2 HENGRUI Medical Introduction and Business Overview
7.7.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.7.4 HENGRUI Medical PVA Embolization Particles Product Offerings
7.7.5 HENGRUI Medical Recent Development
7.8 INterface BIOmaterials
7.8.1 INterface BIOmaterials Company Information
7.8.2 INterface BIOmaterials Introduction and Business Overview
7.8.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.8.4 INterface BIOmaterials PVA Embolization Particles Product Offerings
7.8.5 INterface BIOmaterials Recent Development
7.9 Alicon
7.9.1 Alicon Company Information
7.9.2 Alicon Introduction and Business Overview
7.9.3 Alicon PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Alicon PVA Embolization Particles Product Offerings
7.9.5 Alicon Recent Development
8 Industry Chain Analysis
8.1 PVA Embolization Particles Industrial Chain
8.2 PVA Embolization Particles Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 PVA Embolization Particles Sales Model
8.5.2 Sales Channel
8.5.3 PVA Embolization Particles Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.